Positron Emission Tomography (PET) Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2500
Buy Report View Sample

Published: June 30, 2021 Report Code: GDME1130EPD-ST

Select Item

A Positron Emission Tomography (PET) scan is an imaging test that helps reveal how your tissues and organs are functioning. A PET scan uses a radioactive drug (tracer) to show this activity. GlobalData's Medical Devices sector report, “Positron Emission Tomography (PET) Systems – Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Positron Emission Tomography (PET) Systems pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
The Positron Emission Tomography (PET) Systems Pipeline Landscape report provides key information and data related to:
Extensive coverage of the Positron Emission Tomography (PET) Systems under development
Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates
Reviews of major players involved in the pipeline product development.
Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Positron Emission Tomography (PET) Systems pipeline products.
Review of Recent Developments in the segment / industry
The Positron Emission Tomography (PET) Systems Pipeline Landscape report enables you to:
Access significant competitor information, analysis, and insights to improve your R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Glaucoma Drainage Device sunder development
Formulate market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
The major companies covered in the “Positron Emission Tomography (PET) Systems – Medical Devices Pipeline Product Landscape, 2021” report:
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports
• 64,000+ medical equipment company profiles
• 5,600+ company profiles of medical equipment manufacturers in China and India
• 2,200+ company profiles of medical equipment manufacturers in Japan
• 1,200+ companies’ revenue splits and market shares
• 1,600+ quarterly and annual medical equipment company financials
• 850+ medical equipment company SWOTs
• 28,000+ pipeline product profiles
• 56,400+ marketed product profiles
• 47,000+ clinical trials
• 41,500+ trial investigators
• 7,000+ reports on companies with products in development
• 44,000+ deals in the medical equipment industry
• 1,100+ surgical and diagnostic procedures by therapy area
• 50+ key healthcare indicators by country
• 431,000+ Themes Content Items
• 600+ Influencers
• 1,900+ Analysts & Researchers
• 0.5m+ Community Members
• 141,000+ Macroeconomic Indicators
• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:
https://medical.globaldata.com/home.aspx
Custom Requirements
Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

Extensive coverage of the Positron Emission Tomography (PET) Systems under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Positron Emission Tomography (PET) Systems and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

Identify and understand important and diverse types of Positron Emission Tomography (PET) Systems under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product’s current stage of development, territory and estimated launch date

Brain Biosciences Inc
General De Equipment for Medical Imaging SA
Jagiellonian University
MultiFunctional Imaging LLC
Philips Healthcare
Positrigo AG
Ray Vision Intl Corp.
Stanford University
SynchroPET
University of California Santa Cruz
University of Washington
West Virginia University

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 7

2 Introduction 8

2.1 Positron Emission Tomography (PET) Systems Overview 8

3 Products under Development 9

3.1 Positron Emission Tomography (PET) Systems – Pipeline Products by Stage of Development 9

3.2 Positron Emission Tomography (PET) Systems – Pipeline Products by Territory 10

3.3 Positron Emission Tomography (PET) Systems – Pipeline Products by Regulatory Path 11

3.4 Positron Emission Tomography (PET) Systems – Pipeline Products by Estimated Approval Date 12

3.5 Positron Emission Tomography (PET) Systems – Ongoing Clinical Trials 13

4 Positron Emission Tomography (PET) Systems – Pipeline Products under Development by Companies 14

4.1 Positron Emission Tomography (PET) Systems Companies – Pipeline Products by Stage of Development 14

4.2 Positron Emission Tomography (PET) Systems – Pipeline Products by Stage of Development 15

5 Positron Emission Tomography (PET) Systems Companies and Product Overview 16

5.1 Brain Biosciences Inc Company Overview 16

5.1.1 Brain Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 16

5.2 General De Equipment for Medical Imaging SA Company Overview 18

5.2.1 General De Equipment for Medical Imaging SA Pipeline Products & Ongoing Clinical Trials Overview 18

5.3 Jagiellonian University Company Overview 19

5.3.1 Jagiellonian University Pipeline Products & Ongoing Clinical Trials Overview 19

5.4 MultiFunctional Imaging LLC Company Overview 20

5.4.1 MultiFunctional Imaging LLC Pipeline Products & Ongoing Clinical Trials Overview 20

5.5 Philips Healthcare Company Overview 21

5.5.1 Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 21

5.6 Positrigo AG Company Overview 22

5.6.1 Positrigo AG Pipeline Products & Ongoing Clinical Trials Overview 22

5.7 Ray Vision Intl Corp. Company Overview 23

5.7.1 Ray Vision Intl Corp. Pipeline Products & Ongoing Clinical Trials Overview 23

5.8 Stanford University Company Overview 24

5.8.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 24

5.9 SynchroPET Company Overview 31

5.9.1 SynchroPET Pipeline Products & Ongoing Clinical Trials Overview 31

5.10 University of California Santa Cruz Company Overview 33

5.10.1 University of California Santa Cruz Pipeline Products & Ongoing Clinical Trials Overview 33

5.11 University of Washington Company Overview 34

5.11.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview 34

5.12 West Virginia University Company Overview 37

5.12.1 West Virginia University Pipeline Products & Ongoing Clinical Trials Overview 37

6 Positron Emission Tomography (PET) Systems- Recent Developments 38

6.1 Jun 15, 2021: SNMMI image of the year: PET imaging measures cognitive impairment in covid-19 patients 38

6.2 Jun 15, 2021: Novel radiotracer shows promise to predict abdominal aortic aneurysm rupture 38

6.3 Jun 13, 2021: SNMMI: New super-resolution technique allows for more detailed brain imaging 39

6.4 May 24, 2021: AdAltaand GE Healthcare advance Granzyme BI-bodies into preclinical development, extend collaboration 40

6.5 Apr 23, 2021: UVA develops imaging approach to help stop epilepsy seizures 40

6.6 Mar 12, 2021: Immuno-PET can give physicians early insight into tumor response to targeted therapy 41

6.7 Feb 18, 2021: An efficient method for separating O-18 from O-16, essential for use in cancer treatment 42

6.8 Jan 20, 2021: Expanded PET imaging time window adds convenience and flexibility for neuroendocrine tumor patients 42

6.9 Dec 22, 2020: Advanced infrastructure will improve health research 43

6.10 Dec 09, 2020: New research study to demonstrate value of brain PET scans in diagnosing Alzheimer's in diverse populations 44

6.11 Sep 21, 2020: Global Alzheimer's Platform Foundation selects IXICO for Innovative Bio-Hermes Trial 45

6.12 Sep 21, 2020: Emory first in Georgia to offer patients access to new PET/CT scanner for improved diagnosis and treatment 46

6.13 Sep 15, 2020: Cue Biopharma announces nature methods publication of preclinical data showing tumor penetration and antigen-specific T cell engagement with with Immuno-STAT based protein scaffolds 46

6.14 Jul 15, 2020: Expesicor announces collaboration with Massachusetts General Hospital to develop novel imaging agents for pain management 47

6.15 Jul 12, 2020: Molecular imaging identifies link between heart and kidney inflammation after heart attack 47

6.16 Jul 12, 2020: Novel bone imaging approach provides insights into the progression of knee osteoarthritis 48

7 Appendix 50

7.1 Methodology 50

7.2 About GlobalData 53

7.3 Contact Us 53

Table

Positron Emission Tomography (PET) Systems – Pipeline Products by Stage of Development 9

Positron Emission Tomography (PET) Systems – Pipeline Products by Territory 10

Positron Emission Tomography (PET) Systems – Pipeline Products by Regulatory Path 11

Positron Emission Tomography (PET) Systems – Pipeline Products by Estimated Approval Date 12

Positron Emission Tomography (PET) Systems – Ongoing Clinical Trials 13

Positron Emission Tomography (PET) Systems Companies – Pipeline Products by Stage of Development 14

Positron Emission Tomography (PET) Systems – Pipeline Products by Stage of Development 15

Brain Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 16

CerePET – Product Status 16

CerePET – Product Description 16

FREEMotion – Product Status 17

FREEMotion – Product Description 17

General De Equipment for Medical Imaging SA Pipeline Products & Ongoing Clinical Trials Overview 18

CareMiBrain – Product Status 18

CareMiBrain – Product Description 18

Jagiellonian University Pipeline Products & Ongoing Clinical Trials Overview 19

Jagiellonian-PET TOMOGRAPHY – Product Status 19

Jagiellonian-PET TOMOGRAPHY – Product Description 19

MultiFunctional Imaging LLC Pipeline Products & Ongoing Clinical Trials Overview 20

Dual-Tracer PET Device – Product Status 20

Dual-Tracer PET Device – Product Description 20

Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 21

Additional PET Scan – Product Status 21

Additional PET Scan – Product Description 21

Positrigo AG Pipeline Products & Ongoing Clinical Trials Overview 22

NeuroLF – Product Status 22

NeuroLF – Product Description 22

Ray Vision Intl Corp. Pipeline Products & Ongoing Clinical Trials Overview 23

Helmet – PET System – Product Status 23

Helmet – PET System – Product Description 23

Stanford University Pipeline Products & Ongoing Clinical Trials Overview 24

Breast-Dedicated PET System – Product Status 24

Breast-Dedicated PET System – Product Description 24

Dual Panel PET Scanner – Product Status 25

Dual Panel PET Scanner – Product Description 25

Dual-isotope Positron Emitting Tomography System – Product Status 25

Dual-isotope Positron Emitting Tomography System – Product Description 26

MR Compatible PET System – Product Status 26

MR Compatible PET System – Product Description 26

Next Generation TOF-PET System – Product Status 27

Next Generation TOF-PET System – Product Description 27

PET Sensitivity Enhancing System – Product Status 27

PET Sensitivity Enhancing System – Product Description 28

PET System – Product Status 28

PET System – Product Description 28

Stanford University – Ongoing Clinical Trials Overview 29

Breast-Dedicated PET System – Pilot Study of a Breast-dedicated PET Camera with 1 Millimeter Spatial Resolution 30

SynchroPET Pipeline Products & Ongoing Clinical Trials Overview 31

Arterial PET Scanner – Product Status 31

Arterial PET Scanner – Product Description 31

Breast PET-MRI – Product Status 32

Breast PET-MRI – Product Description 32

University of California Santa Cruz Pipeline Products & Ongoing Clinical Trials Overview 33

Head And Neck PET System – Product Status 33

Head And Neck PET System – Product Description 33

University of Washington Pipeline Products & Ongoing Clinical Trials Overview 34

DS-PS3 Positron Emission Tomography Detector – Product Status 34

DS-PS3 Positron Emission Tomography Detector – Product Description 34

High Resolution PET Detector – Product Status 35

High Resolution PET Detector – Product Description 35

PET-Mammogram-Biopsy System – Product Status 35

PET-Mammogram-Biopsy System – Product Description 36

West Virginia University Pipeline Products & Ongoing Clinical Trials Overview 37

PEM/PET-Breast Imager – Product Status 37

PEM/PET-Breast Imager – Product Description 37

Figures

Positron Emission Tomography (PET) Systems – Pipeline Products by Stage of Development 9

Positron Emission Tomography (PET) Systems – Pipeline Products by Territory 10

Positron Emission Tomography (PET) Systems – Pipeline Products by Regulatory Path 11

Positron Emission Tomography (PET) Systems – Pipeline Products by Estimated Approval Date 12

Frequently asked questions

Positron Emission Tomography (PET) Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 standard reports
Currency USD
$2,500

Can be used by individual purchaser only

Most Popular
$5,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Positron Emission Tomography (PET) Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Diagnostic Imaging reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Positron Emission Tomography (PET) Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 in real time.

  • Access a live Positron Emission Tomography (PET) Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more